Medical News

RSS

Optimized diabetes management with the CONTOUR(R) USB blood glucose meter

Bayer Diabetes Care today announced U.S. Food & Drug Administration clearance to market the CONTOUR(R) USB blood glucose meter. Bayer's CONTOUR USB meter is the first and only blood glucose monitor that plugs directly into a computer providing users with instant access to information that can help optimize diabetes management. The CONTOUR USB meter is integrated with Glucofacts(TM) DELUXE software for easy retrieval of data as well as longer-term tracking and analysis of blood glucose test results.

21 Sep 2009

Nasdaq Stock Market issues noncompliance letter to A.P. Pharma

A.P. Pharma, Inc. (Nasdaq:APPA), a specialty pharmaceutical company, today announced that, on September 15, 2009, the Company received a letter from The Nasdaq Stock Market (Nasdaq) indicating that the minimum closing bid price of its common stock had fallen below $1.00 for 30 consecutive trading days, and therefore, A.P. Pharma was not in compliance with Marketplace Rule 5450(a)(1).

21 Sep 2009

Better visualization of soft tissues using Toshiba's LCI

To continue its commitment to advancing medical imaging technology and improving diagnosis, Toshiba America Medical Systems, Inc. introduces Low-Contrast Imaging (LCI) for Toshiba’s InfinixTM-i systems with mid (12” x 12”) and large (12” x 16”) flat-panel detectors (FPD). Toshiba will demonstrate its low-contrast imaging capabilities at this year’s Transcatheter Cardiovascular Therapeutics (TCT) annual meeting in San Francisco, Sept. 21 – Sept. 25, 2009 (Booth #705).

21 Sep 2009

Public offer to holders of Pharming Group's convertible bonds

Biotech company Pharming Group NV ("Pharming" or the "Company") (NYSE Euronext: PHARM) today announces that it has made a public offer to the holders of convertible bonds (issued in 2007) to convert their bonds into a combination of cash and shares.

21 Sep 2009

Community events conducted by the Hospital at Craig Ranch

...

21 Sep 2009

Ontarians support research involving biotechnology

Ontarians overwhelmingly value biotechnology’s contribution to their lives and the economy, BIOTECanada told Minister Milloy and an audience of over 150 business leaders at the launch of the sixth annual National Biotechnology Week.

21 Sep 2009

The 2009 National Pharmacy Study ranks Prescription Solutions second among mail order pharmacies

Prescription Solutions, a leading pharmacy benefits management (PBM) organization and a UnitedHealth Group (NYSE:UNH) company, today announced that it received the highest rankings for customer service and cost competitiveness factors among mail order pharmacies in the J.D. Power and Associates 2009 National Pharmacy StudySM.

21 Sep 2009

IUPUI offers new graduate program in international research ethics

A "Concentration in International Research Ethics" will be offered by the Department of Philosophy in the IU School of Liberal Arts at Indiana University-Purdue University Indianapolisand the Indiana Center for Bioethics.

21 Sep 2009

Duraprint wristband application process saves hospital time and increases work flow efficiency

In today's busy hospitals, caregivers appreciate products that provide quick and easy application, allowing them to focus more time on patients. Precision Dynamics-TimeMed, the global leader in healthcare identification, streamlines and simplifies the wristband application process with its new DuraPrint® laser printable wristband and label system. Unlike traditional laminated wristbands, DuraPrint's® patented design doesn't require a laminate overlay, which saves hospital time and increases work flow efficiency.

21 Sep 2009

Celebrities take part in competition to mark World Alzheimer's Day

Today, on World Alzheimer's Day, new data released estimates 35 million people worldwide -- a 10% increase over 2005 -- are living with Alzheimer's and dementia, highlighting the urgent need for action and response.

21 Sep 2009

Ipsen's Azzalure muscle relaxant receives Spanish AEMPS marketing approval

Galderma, the leading pharmaceutical company in dermatology, and Ipsen (Euronext: IPN), an international innovation-driven specialty pharmaceutical group, today announced that Azzalure® (botulinum toxin type A manufactured by Ipsen), a local muscle relaxant specifically developed for aesthetic use, has received a marketing authorization in Spain from the Spanish Medicines and Healthcare products Agency (AEMPS) for the temporary improvement in the appearance of moderate to severe glabellar lines seen at the frown (vertical lines between the eyebrows), in adult men and women aged 65 years and under, when the severity of these lines has an important psychological impact on the patient.

21 Sep 2009

Dialysis patient embarks on "Grandpa's Road Trip" with NxStage System One hemodialysis machine

NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that home dialysis patient Harvey Wells, 57, has embarked on his third annual "Grandpa's Road Trip" with the NxStage(R) System One(TM). As a portable home hemodialysis machine, the NxStage System One provides Mr. Wells the opportunity to fit hemodialysis therapy into his own lifestyle and schedule. Mr. Wells is once again celebrating this freedom by traveling the country in his RV and sharing with other patients his experience doing home daily hemodialysis with the NxStage System One.

21 Sep 2009

Three German laboratories utilize Bruker’s molecular identification solution

At the 61st Annual Meeting of the German Society for Hygiene and Microbiology on September 20-23, 2009 in Goettingen, Bruker Daltonics announces that three major German private clinical microbiology laboratories have extended their accreditation according to DIN EN ISO 15189 to include the use of Bruker’s MALDI Biotyper molecular identification solution.

21 Sep 2009

Symposium to discuss the scientific approaches of the FDA

The Second Annual Science Writers Symposium on Nov. 4 and 5, 2009, at the FDA's White Oak campus in Silver Spring, Md., will highlight how the FDA applies novel scientific approaches to critical public health issues and the products it regulates. The symposium, featuring a lab tour and presentations by FDA scientists, will give writers a unique insight into the evolving field of regulatory science with an eye towards generating potential story ideas.

21 Sep 2009

Widespread misinformation about Obama's healthcare proposals

A new Harris Poll finds that large numbers of people either believe damaging misinformation about the health care proposals being discussed in Washington or are not sure what to believe. The polls also shows that almost half of all adults continue to support what they see as President Obama’s health care reform proposals, significantly but not substantially more than oppose them.

21 Sep 2009

UltraPulse SurgiTouch CO2 laser for the treatment of airway stenosis

Lumenis Ltd., the world's largest medical laser company, announced today that it supplied an UltraPulse SurgiTouch CO2 laser with Digital AcuBlade microsurgery system to the Landspitalinn University Hospital in Reykjavik, Iceland. Lumenis' state of the art laser system, was used by Dr. Paul Castellanos to perform Trans-oral Laser Microsurgery (TLM) for the treatment of airway stenosis with obstructing neurofibromatosis of the laryngopharynx on a 9-year-old girl and four other patients.

From Lumenis Inc. 21 Sep 2009

NASDAQ issues noncompliance letter to Sunesis Pharmaceuticals

Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) reported today that it received a letter, dated September 16, 2009, from the Listing Qualifications Staff (the "Staff") of The NASDAQ Stock Market notifying Sunesis that it does not comply with the minimum $1.00 per share requirement for continued listing on The NASDAQ Capital Market set forth in NASDAQ Listing Rule 5550(a)(2).

21 Sep 2009

EPIC's stock dividend postponed due to joint venture

EPIC Corporation, a financial services company, announced the formation of a joint venture, Hallmark Heritage, LLC, with Level 3 Capital Partners, LLC, and Senior Care Group, Inc.; the formation of Senior Care Communities Trust, Inc., and, in light of entering into the joint venture, EPIC's board of directors postponed the stock dividend announced in May 2009.

21 Sep 2009

Vaccine Global Congress organized by Elsevier's Vaccine journal

Elsevier, a leading publisher of scientific, technical and medical information products and services, announced today, that its journal Vaccine, the most comprehensive and pre-eminent journal for those interested in vaccines and vaccination, will organize the 3rd Vaccine Global Congress from 4-6 October, 2009, in Singapore.

21 Sep 2009

March of Dimes to re-launch Healthy Baby program for military families

Military moms whose babies were born too soon or too sick were treated to a very special baby shower today at the Portsmouth Naval Medical Center Neonatal Intensive Care Unit (NICU) courtesy of the March of Dimes and Operation Shower.

21 Sep 2009